Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 4/2020

01-07-2020 | Breast Cancer | Correction

Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)

Authors: Hitoshi Tsuda, Koichiro Tsugawa, Futoshi Akiyama, Rie Horii, Masafumi Kurosumi, Takuya Moriya, Toshimi Takano, Hiroyuki Takei, Takahiro Nakayama, Yumi Miyagi, Chikako Yamauchi, Toshinari Yamashita, Kenjiro Aogi, Hirofumi Mukai, Tomoharu Sugie, Hiroji Iwata, Shinobu Masuda

Published in: Breast Cancer | Issue 4/2020

Login to get access

Excerpt

In the original publication of the article, the author group and acknowledgements were published incorrectly. The correct author group and acknowledgements are given in this correction. …
Metadata
Title
Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)
Authors
Hitoshi Tsuda
Koichiro Tsugawa
Futoshi Akiyama
Rie Horii
Masafumi Kurosumi
Takuya Moriya
Toshimi Takano
Hiroyuki Takei
Takahiro Nakayama
Yumi Miyagi
Chikako Yamauchi
Toshinari Yamashita
Kenjiro Aogi
Hirofumi Mukai
Tomoharu Sugie
Hiroji Iwata
Shinobu Masuda
Publication date
01-07-2020
Publisher
Springer Japan
Published in
Breast Cancer / Issue 4/2020
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-020-01106-y

Other articles of this Issue 4/2020

Breast Cancer 4/2020 Go to the issue

Special Article

Annual report of the Japanese Breast Cancer Society registry for 2016

Original Article

The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer

Original Article

Breast cancer risk prediction models and subsequent tumor characteristics

Original Article

Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancer

Original Article

The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways

Case Report

Everolimus-associated cytomegalovirus colitis in a patient with metastasized breast cancer: a case report
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits